TRNDS | University of Rochester

Technology & Rare Neurological Diseases Symposium

TRNDS is a national symposium on emerging novel therapeutic technologies that are creating new and rapidly expanding treatment options for patients with rare neurological disorders. TRNDS is hosted and organized by the University of Rochester, a national leader in rare disease research and therapeutic development.

Subscribe for TRNDS updates and rare disease news

September 13, 2019

7:30 am – 4:00 pm

University of Rochester
Saunders Research Building
265 Crittenden Boulevard
Rochester, NY 14620

TRNDS | University of Rochester

Technology & Rare Neurological Diseases Symposium

TRNDS is a national symposium on emerging novel therapeutic technologies that are creating new and rapidly expanding treatment options for patients with rare neurological disorders. TRNDS is hosted and organized by the University of Rochester, a national leader in rare disease research and therapeutic development.

Subscribe for TRNDS updates and rare disease news

September 13, 2019

7:30 am – 4:00 pm

University of Rochester
Saunders Research Building
265 Crittenden Boulevard
Rochester, NY 14620

LEARN

Learn the latest research behind breakthrough health technologies for rare neurological disorders.

DISCOVER

Discover new ideas and innovations driving therapy development, clinical trials and clinical research.

JOIN

Join a community of renowned experts dedicated to accelerating the discovery of new therapies.

TRNDS Speakers

TRNDS 2019 speakers include leading clinical researchers, forward-thinking health technology leaders, influential patient advocates, and experts in regulatory science. Confirmed speakers include:

TRNDS Topics

TRNDS 2019 program will focus on emerging gene therapy approaches, a new era in enzyme replacement therapy, the future of newborn screening, and novel tools and technologies contributing to the modernization of clinical research. Topics include:

Emerging approaches to treating serious, rare neurological conditions

Personalized medicine in a neurological disease framework

Developing pathways to early diagnosis

Novel technologies to facilitate high quality, efficient clinical studies

Ethical considerations in the modernization of clinical trials and therapies

Latest News

Stay informed of current rare disease news and TRNDS updates

Subscribe for TRNDS updates and rare disease news

  • FDA Cancer Office Taps Syapse for Real-world Evidence Development
    READ MORE
  • NIH All of Us Project Tops 270,000 Sign-ups
    READ MORE
  • Ultragenyx Partners with GeneTx to Advance Treatment for Angelman Syndrome
    READ MORE
  • Antisense Drugs for HD, ALS & Prion Could Meet the Need for Brain Treatments
    READ MORE

TRNDS 2019 Sponsors

Industry-leading TRNDS sponsors represent innovative companies and organizations that share a common vision and mission: to advance therapy development for rare neurological diseases.

Center for Health + Technology, University of Rochester
CTSI University of Rochester Medical Center TRNDS
REGENXBIO TRNDS